- No public price.
- Not disclosed
- Not disclosed
- —
- —
- US
Decision support
Lucem Health
by Lucem Health · US
Platform that deploys AI risk models on health data to find likely undiagnosed or higher-risk patients for follow-up.
On this page
5/100
Not rated: too little independent evidence yet.
- Regulatory & Compliance0/22
No FDA clearance listed
- Clinical Integration0/11.6
No EHR integrations listed
- Evidence Strength0/30
No peer-reviewed coverage
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency1.3/2.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/6
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/5
None of the top-3 EHRs covered
- Bidirectional write-back0/1
No bidirectional write-back documented
- Peer-reviewed papers0/21
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/9
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Pricing transparency1/3
Pricing on request, no public amounts
Platform that deploys AI risk models on health data to find likely undiagnosed or higher-risk patients for follow-up.
No public price.
Evidence record
No FDA decision cited in our research as of November 2, 2026.
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Lucem Health record, https://medaiverdict.com/tools/lucem-health, version November 2, 2026
Bottom line
Lucem Health sells Reveal, a set of AI risk-model programs for arrhythmias, colorectal cancer, liver disease, lung cancer and type 1 diabetes, offered to providers and life sciences companies. The homepage says the programs use existing health data to find patients who are undiagnosed or at higher risk. Mayo Clinic helped launch the company, which the site says started "with Mayo Clinic," and led its 2023 Series A. The homepage does not say who built or validated the models.
What does Reveal offer?
The homepage says Lucem "helps healthcare providers accelerate disease detection and treatment using practical, responsible AI," that Reveal is built to fit clinical workflows and that it uses "validated clinical AI models." A separate "Disease Insights" offer sits next to it, and the site says the company serves "providers and life sciences companies." HLTH's May 2023 coverage of the funding round described a different pitch, a platform connecting remote patient telemetry devices with AI algorithms.
The homepage puts a multiplier on four of the programs: up to 8 times better colorectal cancer detection, 47 times better screening efficiency for type 1 diabetes, 3 times better liver disease detection and 8 times better screening efficiency for lung cancer. PubMed returns no paper on Lucem Health.
Who owns it and who has backed it?
Lucem Health, Inc. is listed in Davidson, North Carolina by HIT Consultant and Dealroom and in Raleigh by Crunchbase. According to Healthcare IT News, Mayo Clinic and Commure launched the company as part of the Mayo Clinic Platform. A $7.7 million Series A, reported by HIT Consultant on May 10, 2023 and HLTH the next day, was led by Mayo Clinic, Granger Management and Mercy of St. Louis, with existing investor Rally Ventures. The "Trusted by" row shows logos for Mayo Clinic Platform and Mercy Hospital St. Louis. Founders and founding year are not on the site, and neither a price nor any EHR integration, HIPAA, SOC 2 or HITRUST statement appears there.
The verdict
A clinician who wants a tool to use during a visit would look elsewhere, since the homepage describes programs that use existing health data to find patients. The audience is a health system analytics team or a life sciences company that wants programs for these five conditions, with Mayo Clinic as launch partner and Series A lead. The homepage does not say which models sit behind each program.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. |
Source: vendor pricing page. Last checked November 2, 2026.
Other decision support
See the full decision support rankingUpToDate Expert AI
by Wolters Kluwer
Generative AI version of UpToDate that answers only from UpToDate's expert-authored library. Included in UpToDate subscriptions in the US.
July 2026 figure from a third-party price comparison; the vendor page shows no amount. Wolters Kluwer states Expert AI is included in all UpToDate subscriptions in the US. Trainees $219 per year with proof.
OpenEvidence
by OpenEvidence
Free physician-only literature-grounded Q&A, 1M consults/day.
Free for NPI-verified physicians (ad-funded).
Doximity Ask
by Doximity
Free clinical AI assistant for verified US clinicians, built on Pathway's technology.
Free for verified US clinicians, funded by advertising, per third-party summaries. Doximity's pages returned 403 when read. Also part of enterprise contracts with health systems.DynaMed / Dyna AI
by EBSCO Health
Evidence-based clinical reference from EBSCO with Dyna AI, a generative Q&A add-on, and Epic integration.
Individual plan from the EBSCO store.